Regional hypometabolism in the 3xTg mouse model of Alzheimer's disease

Regional hypometabolism in the 3xTg mouse model of Alzheimer's disease

Alzheimer's disease (AD) is a progressive age-related neurodegenerative disease. Although neurofibrillary tangles and amyloid beta are classic hallmarks of AD, the earliest deficits in AD progression may be caused by unknown factors. One suspected factor has to do with brain energy metabolism....

Full description

Bibliographic Details
Main Authors:	Aida Adlimoghaddam, Wanda M. Snow, Greg Stortz, Claudia Perez, Jelena Djordjevic, Andrew L. Goertzen, Ji Hyun Ko, Benedict C. Albensi
Format:	Article
Language:	English
Published:	Elsevier 2019-07-01
Series:	Neurobiology of Disease
Subjects:	Alzheimer's disease, 3xTg-AD, neurofibrillary tangles Amyloid beta FDG-PET Insular Pirifom
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996118302663

Similar Items

Early Onset of Sex-Dependent Mitochondrial Deficits in the Cortex of 3xTg Alzheimer’s Mice
by: Jelena Djordjevic, et al.
Published: (2020-06-01)

Systematic Phenotyping and Characterization of the 3xTg-AD Mouse Model of Alzheimer’s Disease
by: Dominic I. Javonillo, et al.
Published: (2022-01-01)

Sex-Specific Effects of Chronic Creatine Supplementation on Hippocampal-Mediated Spatial Cognition in the 3xTg Mouse Model of Alzheimer’s Disease
by: Wanda M. Snow, et al.
Published: (2020-11-01)

Olfactory dysfunction in the 3xTg-AD model of Alzheimer’s disease
by: Darlene A. Mitrano, et al.
Published: (2021-06-01)

Neuroprotective Effect of Nosustrophine in a 3xTg Mouse Model of Alzheimer’s Disease
by: Iván Carrera, et al.
Published: (2023-09-01)

Low-Dose Chidamide Treatment Displays Sex-Specific Differences in the 3xTg-AD Mouse
by: Jessica Dennison, et al.
Published: (2023-08-01)

Neuropathological and behavioral features of an APP/PS1/MAPT (6xTg) transgenic model of Alzheimer’s disease
by: Sung Hyun Tag, et al.
Published: (2022-06-01)

Aducanumab: A new hope in Alzheimer's disease
by: Rouchan Ali, et al.
Published: (2022-09-01)

Differential effects of chronic immunosuppression on behavioral, epigenetic, and Alzheimer’s disease-associated markers in 3xTg-AD mice
by: Minesh Kapadia, et al.
Published: (2021-01-01)

IntelliCage Automated Behavioral Phenotyping Reveals Behavior Deficits in the 3xTg-AD Mouse Model of Alzheimer’s Disease Associated With Brain Weight
by: Wendy Winslow, et al.
Published: (2021-08-01)

Cognitive Impairment in the 3xTg-AD Mouse Model of Alzheimer’s Disease is Affected by Aβ-ImmunoTherapy and Cognitive Stimulation
by: Alejandro R. Roda, et al.
Published: (2020-10-01)

Both Amyloid-β Peptide and Tau Protein Are Affected by an Anti-Amyloid-β Antibody Fragment in Elderly 3xTg-AD Mice
by: Alejandro R. Roda, et al.
Published: (2020-09-01)

Advances in Alzheimer’s disease therapeutics: biochemistry, exploring bioactive compounds and novel approaches
by: Ayomide Victor Atoki, et al.
Published: (2023-09-01)

The neuropathological diagnosis of Alzheimer’s disease
by: Michael A. DeTure, et al.
Published: (2019-08-01)

Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice
by: Eleonora Daini, et al.
Published: (2023-01-01)

Digging Signatures in 13-Month-Old 3xTg-AD Mice for Alzheimer's Disease and Its Disruption by Isolation Despite Social Life Since They Were Born
by: Lydia Gimenez-Llort, et al.
Published: (2021-01-01)

Age-dependent modifications of AMPA receptor subunit expression levels and related cognitive effects in 3xTg-AD mice
by: Pamela eCantanelli, et al.
Published: (2014-08-01)

Whole Blood Transcriptome Characterization of 3xTg-AD Mouse and Its Modulation by Transcranial Direct Current Stimulation (tDCS)
by: Chiara Magri, et al.
Published: (2021-07-01)

Treadmill exercise prevents the hyperexcitability of pyramidal neurons in medial entorhinal cortex in the 3xTg-AD mouse model of Alzheimer's disease
by: Huimin Chen, et al.
Published: (2023-10-01)

Inhibition of PLK2 activity affects APP and tau pathology and improves synaptic content in a sex-dependent manner in a 3xTg mouse model of Alzheimer's disease
by: Laura Martínez-Drudis, et al.
Published: (2022-10-01)

Vitamin E therapy prevents the accumulation of congophilic amyloid plaques and neurofibrillary tangles in the hippocampus in a rat model of Alzheimer’s disease
by: Mehrdad Jahanshahi, et al.
Published: (2020-01-01)

Emerging Signal Regulating Potential of Genistein Against Alzheimer’s Disease: A Promising Molecule of Interest
by: Md. Sahab Uddin, et al.
Published: (2019-09-01)

Brain ethanolamine phospholipids, neuropathology and cognition: A comparative post-mortem analysis of structurally specific plasmalogen and phosphatidyl species
by: Dayan B. Goodenowe, et al.
Published: (2022-08-01)

Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review
by: Christian Benedict, et al.
Published: (2018-04-01)

Attenuation of HECT-E3 ligase expression rescued memory deficits in 3xTg-AD mice
by: Pavithra Suresh, et al.
Published: (2022-07-01)

Extracellular Vesicles From 3xTg-AD Mouse and Alzheimer’s Disease Patient Astrocytes Impair Neuroglial and Vascular Components
by: Luis Alfonso González-Molina, et al.
Published: (2021-02-01)

Alterations of the Sympathoadrenal Axis Related to the Development of Alzheimer’s Disease in the 3xTg Mouse Model
by: Alicia Muñoz-Montero, et al.
Published: (2022-03-01)

Spatial and Temporal Protein Modules Signatures Associated with Alzheimer Disease in 3xTg-AD Mice Are Restored by Early Ubiquinol Supplementation
by: Emilio Llanos-González, et al.
Published: (2023-03-01)

Transfusion with Blood Plasma from Young Mice Affects rTg4510 Transgenic Tau Mice Modeling of Alzheimer’s Disease
by: Carlos M. Hernandez, et al.
Published: (2023-05-01)

A TOMM40/APOE allele encoding APOE‐E3 predicts high likelihood of late‐onset Alzheimer’s disease in autopsy cases
by: Selma M. Soyal, et al.
Published: (2020-08-01)

How Many Alzheimer–Perusini’s Atypical Forms Do We Still Have to Discover?
by: Luigi Donato, et al.
Published: (2023-07-01)

Cyclic multiplex fluorescent immunohistochemistry and machine learning reveal distinct states of astrocytes and microglia in normal aging and Alzheimer’s disease
by: Clara Muñoz-Castro, et al.
Published: (2022-02-01)

Deciphering the Astrocyte Reaction in Alzheimer’s Disease
by: Beatriz G. Perez-Nievas, et al.
Published: (2018-04-01)

Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer’s disease
by: Bhaskar C Das, et al.
Published: (2019-01-01)

Aβ plaques
by: Lary C Walker
Published: (2020-10-01)

Amyloid Beta in Aging and Alzheimer’s Disease
by: Ujala Sehar, et al.
Published: (2022-10-01)

From Small Peptides to Large Proteins against Alzheimer’sDisease
by: Pasquale Picone, et al.
Published: (2022-09-01)

Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence
by: Ali Azargoonjahromi, et al.
Published: (2024-03-01)

Selective In Vitro and Ex Vivo Staining of Brain Neurofibrillary Tangles and Amyloid Plaques by Novel Ethylene Ethynylene-Based Optical Sensors
by: Florencia A. Monge, et al.
Published: (2023-01-01)

Current progress of cerebral organoids for modeling Alzheimer's disease origins and mechanisms
by: Sai Sreenivasamurthy, et al.
Published: (2023-03-01)